Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Sienna Biopharmaceuticals Inc (SNNA)

Sienna Biopharmaceuticals Inc (SNNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,197
  • Shares Outstanding, K 30,908
  • Annual Sales, $ 0 K
  • Annual Income, $ -73,470 K
  • 60-Month Beta 2.67
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.18
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.03
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/28/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.93
  • Growth Rate Est. (year over year) +107,519.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.06 +112.19%
on 12/13/19
0.28 -52.35%
on 11/19/19
-0.07 (-35.33%)
since 11/15/19
3-Month
0.06 +112.19%
on 12/13/19
0.44 -69.07%
on 11/14/19
-0.54 (-79.83%)
since 09/16/19
52-Week
0.06 +112.19%
on 12/13/19
3.80 -96.43%
on 01/07/19
-3.34 (-96.10%)
since 12/14/18

Most Recent Stories

More News
Delisting of Securities of Yangtze River Port and Logistics Limited, USA Technologies, Inc., Sienna Biopharmaceuticals, Inc., Melinta Therapeutics, Inc., and Jason Industries, Inc., from The Nasdaq Stock Market

The Nasdaq Stock Market announced today that it will delist the common stock of Yangtze River Port and Logistics Limited. Yangtze River Port and Logistics Limited's stock was suspended on August 20, 2019...

MLNT : 0.4400 (-12.00%)
NDAQ : 95.22 (+1.34%)
SNNA : 0.14 (+34.46%)
USAT : 4.4000 (-6.38%)
Sebacia Announces Leadership Update and Acquisition of Silver Photoparticle Technology Assets from Sienna Biopharmaceuticals

Sebacia, Inc., a privately held commercial stage dermatology and aesthetics company, today provided a business update, first announcing an update to its leadership team. Mr. Chuck Abraham has been appointed...

SNNA : 0.14 (+34.46%)
Company News For Nov 19, 2019

Companies in the news are: KRTX, EROS, CARO, SNNA

CARO : 24.72 (-3.96%)
EROS : 1.4300 (-2.05%)
SNNA : 0.14 (+34.46%)
KRTX : 62.29 (-4.05%)
Sienna Biopharmaceuticals Announces Court Approval of Chapter 11 Bidding Procedures

Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA) (the "Company"), a clinical-stage biopharmaceutical company, today announced that, on November 13, 2019, the United States Bankruptcy Court for the District...

SNNA : 0.14 (+34.46%)
Sienna Biopharmaceuticals Announces Successful Appeal of Nasdaq Delisting Notice

-- Sienna's common stock to remain conditionally listed during the Chapter 11 asset sale process

SNNA : 0.14 (+34.46%)
Sienna Biopharmaceuticals Files 510(k) Submission with FDA for SNA-001, its Novel Silver Photoparticle Technology to Remove Light Hair

Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that the Company has filed a Premarket Notification 510(k) submission to the U.S. Food and Drug...

SNNA : 0.14 (+34.46%)
Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection Proceeding

Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that it has elected to file a voluntary petition to allow restructuring under Chapter 11 of the...

SNNA : 0.14 (+34.46%)
Medical devices Market Segmentation, Application, Technology & Market Analysis Research Report

ANIK : 27.83 (-6.23%)
CYNO : 66.15 (+0.23%)
HOLX : 32.82 (-3.64%)
RVNC : 13.69 (+0.22%)
SNNA : 0.14 (+34.46%)
ELOS : 11.00 (unch)
VRX.TO : 30.80 (-3.33%)
Sienna Biopharmaceuticals Engages Cowen to Explore Financial and Strategic Alternatives

Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that the Company has retained Cowen as an independent financial advisor to assist in exploring...

SNNA : 0.14 (+34.46%)
Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference

Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief Executive Officer of Sienna,...

SNNA : 0.14 (+34.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade SNNA with:

Business Summary

Sienna Biopharmaceuticals Inc. is a medical dermatology and aesthetics company. It provides products for inflammatory skin diseases, tissue injury and unwanted light-pigmented hair reduction. The company operates primarily in the United States and Italy. Sienna Biopharmaceuticals Inc. is based in Westlake...

See More

Key Turning Points

2nd Resistance Point 0.20
1st Resistance Point 0.17
Last Price 0.14
1st Support Level 0.10
2nd Support Level 0.07

See More

52-Week High 3.80
Fibonacci 61.8% 2.37
Fibonacci 50% 1.93
Fibonacci 38.2% 1.49
Last Price 0.14
52-Week Low 0.06

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar